Related Experiment Videos
Allergic reactions to Triatoma bites
John E Moffitt1, Daniel Venarske, Jerome Goddard
1Department of Pediatrics, University of Mississippi Medical Center, Jackson, Mississippi 39216, USA. jemoffitt@ped.umsmed.edu
Summary
Triatoma bug bites can cause severe allergic reactions, including anaphylaxis, particularly in the western United States. Further research is needed to understand the full scope of these reactions and develop diagnostic and treatment options.
Area of Science:
- Medical Entomology
- Allergology
- Immunology
Background:
- Triatoma bugs, known vectors of Chagas disease, also cause local cutaneous reactions and anaphylaxis in the United States.
- Allergic reactions to Triatoma bites often occur nocturnally and may go unrecognized.
- The full extent of medical complications from Triatoma bites remains undefined.
Purpose of the Study:
- To review the medical literature on Triatoma allergy.
- To identify current knowledge gaps regarding Triatoma allergy.
- To establish future research directions for Triatoma allergy.
Main Methods:
- Comprehensive search of English-language medical literature using computerized databases.
- Inclusion of articles on Triatoma bites, allergy, entomology, and Chagas disease (US-limited).
- Focus on articles directly relevant to Triatoma allergy and its clinical implications.
Main Results:
- Triatoma bug bites have been a recognized cause of anaphylaxis for over a century.
- Procalin identified as a major salivary allergen in Triatoma protracta, with recombinant expression achieved.
- Allergenic reactivity demonstrated in salivary gland extracts of two species; no cross-reactivity observed.
- Limited immunotherapy trials using salivary gland extract showed potential benefit, but no commercial allergen is available.
Conclusions:
- Triatoma bites represent a significant cause of anaphylaxis, predominantly in the western and southwestern US.
- The incidence of allergic reactions is unclear due to nocturnal exposure during sleep.
- Epidemiologic studies are crucial to determine the prevalence and range of allergic responses.
- Development of a commercial allergen is essential for improved diagnostics and treatment, potentially under the Orphan Drug Act.